Featured

Exclusive: HealthCRED’s Founders on their Vision for Expanding Healthcare Finance in India September 5, 2024 In this exclusive interview with DHN, Shrey Jain and Arpit Jangir, HealthCRED's founders, discuss their strategic plans for expansion, innovation, and the long-term impact they aim to make in the Indian healthcare sector.

Exclusive: Alyve Health's Approach to Streamlining Healthcare Payments in India's Healthtech Sector September 3, 2024 In an exclusive interview with DHN, Sushant Roy, co-founder, CBO, and COO at Alyve Health, shares how Alyve Pay is transforming healthcare payments.

Leveraging Technology for a Nutritious Diet: Innovations from India September 3, 2024 In today's fast-paced world, keeping up with a nutritious diet can be quite challenging. With urban lifestyles becoming the norm, access to fresh, healthy food is a growing concern.

2024’s Major Cybersecurity Breaches in the Healthcare Space September 1, 2024 Months to go before the year 2024 ends, however, the healthcare sector has already encountered an alarming number of cyberattacks. With over 280 incidents reported so far, these breaches represent 24% of all cyber events in the United States alone.

Indian Researchers Driving Healthtech Innovation in India August 28, 2024 Indian Researchers Driving Healthtech Innovation in India

How Deep Tech is Transforming Drug Discovery, Manufacturing, & Distribution August 27, 2024 Authored by Madhur Singhal, Managing Partner, Pharma and Lifesciences at Praxis Global Alliance

How AI Tools Are Transforming Patient Care August 24, 2024 In this article, we’ll explore a range of AI tools that are reshaping patient care and transforming the healthcare landscape.

Why Do Healthcare Vertical Need GEN AI? August 23, 2024 Written by - Mohit Tandon, GM-IT, Sri Balaji Action Medical Institute & Action Cancer Hospital

Impact of Customs Duty Exemptions on Cancer Drugs: Analysis August 21, 2024 In a significant move aimed at improving cancer treatment accessibility in India, Union Finance Minister Nirmala Sitharaman recently announced the exemption of customs duties on three crucial cancer drugs: Trastuzumab Deruxtecan, Osimertinib, and Durvalumab.

India's X-Ray Sector Set for Change with Custom Duty Reductions August 15, 2024 Speaking exclusively with DHN, Kabir Mahajan, Associate Director at Mahajan Imaging & Labs, explained that while the decrease in duties should eventually lower costs for digital X-Ray machines, achieving a fully self-sufficient domestic manufacturing base may take several years.

How Technology is Transforming Elderly Care in India August 3, 2024 India's rapidly growing elderly population presents significant healthcare challenges, necessitating innovative solutions to ensure their well-being. The family has traditionally provided care for the elderly, especially in India.

Digitalization of Healthcare Processes and Workflows Imperative for Progress: Dr Priyanka Chauhan August 3, 2024 In an exclusive interview, Arti Ghargi, Sr Industry Analyst, DHN, speaks to Dr Priyanka Chauhan, Sr Product Manager of Digital Health Standards at NABH.